Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
RMD Open
|
February 23, 2024
New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis
Alessandro Tomelleri, Christian Dejaco
European Journal of Internal Medicine
|
December 10, 2024
Redefining giant cell arteritis: From current practices to future paradigms
Alessandro Tomelleri, Nicola Farina, Lorenzo Dagna
Rheumatology (Oxford, England)
|
September 11, 2019
Bilateral temporal arteries 18F-FDG PET uptake in giant cell arteritis
Alessandro Tomelleri, Veronica Bandini, Corrado Campochiaro
European Journal of Internal Medicine
|
July 16, 2014
An enlightening scan
Lorenzo Canziani, Alessandro Tomelleri, Giulio Cavalli
Rheumatology (Oxford, England)
|
November 24, 2020
Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference
Alessandro Tomelleri, Alwin Sebastian, Bhaskar Dasgupta
The New England Journal of Medicine
|
March 17, 2021
Spontaneous Coronary-Artery Dissection
Corrado Campochiaro, Alessandro Tomelleri, Lorenzo Dagna
Reumatismo
|
February 13, 2025
To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis
Alessandro Tomelleri, Christian Dejaco, Milena Bond
Annals of the Rheumatic Diseases
|
July 3, 2021
Response to 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'' by Montero <i>et al</i>
Alessandro Tomelleri, Lorenzo Dagna, Corrado Campochiaro
European Journal of Internal Medicine
|
July 2, 2021
Myocardial infarction in giant cell arteritis: It is all a matter of balance
Alessandro Tomelleri, Corrado Campochiaro, Lorenzo Dagna
The Lancet. Rheumatology
|
March 30, 2021
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation - Authors' reply
Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
RMD Open
|
February 23, 2024
New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis
Alessandro Tomelleri, Christian Dejaco
European Journal of Internal Medicine
|
December 10, 2024
Redefining giant cell arteritis: From current practices to future paradigms
Alessandro Tomelleri, Nicola Farina, Lorenzo Dagna
Rheumatology (Oxford, England)
|
September 11, 2019
Bilateral temporal arteries 18F-FDG PET uptake in giant cell arteritis
Alessandro Tomelleri, Veronica Bandini, Corrado Campochiaro
European Journal of Internal Medicine
|
July 16, 2014
An enlightening scan
Lorenzo Canziani, Alessandro Tomelleri, Giulio Cavalli
Rheumatology (Oxford, England)
|
November 24, 2020
Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference
Alessandro Tomelleri, Alwin Sebastian, Bhaskar Dasgupta
The New England Journal of Medicine
|
March 17, 2021
Spontaneous Coronary-Artery Dissection
Corrado Campochiaro, Alessandro Tomelleri, Lorenzo Dagna
Reumatismo
|
February 13, 2025
To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis
Alessandro Tomelleri, Christian Dejaco, Milena Bond
Annals of the Rheumatic Diseases
|
July 3, 2021
Response to 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'' by Montero <i>et al</i>
Alessandro Tomelleri, Lorenzo Dagna, Corrado Campochiaro
European Journal of Internal Medicine
|
July 2, 2021
Myocardial infarction in giant cell arteritis: It is all a matter of balance
Alessandro Tomelleri, Corrado Campochiaro, Lorenzo Dagna
The Lancet. Rheumatology
|
March 30, 2021
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation - Authors' reply
Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Page
of 13